Top Stories

Solar Energy Is Now the World’s Cheapest Source of Power, a Surrey Study Finds

Solar energy is now so cost-effective that, in the sunniest countries, it costs as little as £0.02 to produce one unit of power, making it cheaper than electricity generated from coal, gas or wind, according to a new study from the University of Surrey.

>> Read the Full Article

Panama Canal May Face Frequent Extreme Water Lows in Coming Decades

A new study found historic droughts could become common for gatún lake, the main source of water for the Panama canal locks.

>> Read the Full Article

2023 Ocean Heatwave ‘Unprecedented but Not Unexpected’

The June 2023 heatwave in northern European seas was “unprecedented but not unexpected”, new research shows.

>> Read the Full Article

Snow Leopards’ Low Genetic Diversity Puts Future at Risk

There are relatively few snow leopards in the world, and it has likely been that way for a long time, a new study indicates.

>> Read the Full Article

Marine Heatwaves Have Hidden Impacts on Ocean Food Webs and Carbon Cycling

New research shows that marine heatwaves can reshape ocean food webs, which in turn can slow the transport of carbon to the deep sea and hamper the ocean’s ability to buffer against climate change.

>> Read the Full Article

Mercury Rising: Why Emissions of This Deadly Neurotoxin May Soon Increase

A recent study revealed that atmospheric levels of mercury have decreased almost 70 percent in the last 20 years, thanks to domestic and global environmental regulations limiting mercury and its emissions.

>> Read the Full Article

How Sustainable Are Reusable Cups? a New Tool Aims to Find Out

Imagine you have just finished a delicious to-go meal or morning coffee, or used the last drop of moisturizer.

>> Read the Full Article

Clam Shells Sound Warning of Atlantic ‘Tipping Point’

A study of clam shells suggests Atlantic Ocean currents may be approaching a “tipping point”.

>> Read the Full Article

Common Inexpensive Drug Halves Recurrence in Colorectal Cancer

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk of recurrence after surgery in patients with colon and rectal cancer with a certain type of genetic alteration in the tumor.

>> Read the Full Article